US Stock MarketDetailed Quotes

TARA Protara Therapeutics

Watchlist

1.890
+0.060+3.28%

Close Sep 27 16:00 ET

38.99MMarket Cap-623P/E (TTM)

Protara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-12.18%10.66M

21.77%11.85M

16.16%43.61M

10.50%11.04M

34.19%10.7M

39.46%12.14M

-10.50%9.73M

-20.94%37.55M

-2.87%9.99M

-26.37%7.97M

Selling and administrative expenses

-12.65%4.27M

-10.59%4.1M

-10.19%18.62M

-6.86%4.66M

-0.58%4.48M

-12.95%4.89M

-18.13%4.59M

-21.45%20.74M

-19.55%5M

-33.09%4.51M

-General and administrative expense

-12.65%4.27M

-10.59%4.1M

-10.19%18.62M

-6.86%4.66M

-0.58%4.48M

-12.95%4.89M

-18.13%4.59M

-21.45%20.74M

-19.55%5M

-33.09%4.51M

Research and development costs

-11.87%6.39M

50.65%7.75M

48.67%24.99M

27.90%6.38M

79.40%6.22M

134.99%7.25M

-2.39%5.14M

-20.30%16.81M

22.64%4.99M

-15.32%3.47M

Operating profit

12.18%-10.66M

-21.77%-11.85M

-16.16%-43.61M

-10.50%-11.04M

-34.19%-10.7M

-39.46%-12.14M

10.50%-9.73M

20.94%-37.55M

2.87%-9.99M

26.37%-7.97M

Net non-operating interest income expense

35.04%1.14M

8.73%747K

191.03%3.18M

55.05%814K

196.11%838K

407.23%842K

477.31%687K

361.18%1.09M

789.83%525K

433.96%283K

Non-operating interest income

35.04%1.14M

8.73%747K

42.65%3.18M

28.80%814K

50.45%838K

64.45%842K

29.87%687K

12.97%2.23M

22.48%632K

1.83%557K

Non-operating interest expense

----

-34.54%1.14M

-76.59%107K

-44.53%274K

Other net income (expense)

175.00%11K

100.04%12K

-29.5M

Gain on sale of security

175.00%11K

--9K

-29.41%12K

--6K

--2K

--4K

----

--17K

----

Special income (charges)

----

--0

----

---29.52M

----

-Less:Impairment of capital assets

----

--0

----

--29.52M

----

Income before tax

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

Income tax

Net income

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

Net income continuous Operations

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

Minority interest income

Net income attributable to the parent company

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

15.77%-9.51M

-22.66%-11.1M

38.71%-40.42M

73.77%-10.22M

-28.20%-9.86M

-32.26%-11.29M

15.90%-9.05M

-39.58%-65.95M

-280.98%-38.97M

28.64%-7.69M

Basic earnings per share

55.00%-0.45

-21.25%-0.97

39.08%-3.57

73.99%-0.9

-27.94%-0.87

-31.58%-1

16.67%-0.8

-39.19%-5.86

-280.22%-3.46

29.17%-0.68

Diluted earnings per share

55.00%-0.45

-21.25%-0.97

39.08%-3.57

73.99%-0.9

-27.94%-0.87

-31.58%-1

16.67%-0.8

-39.19%-5.86

-280.22%-3.46

29.17%-0.68

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-12.18%10.66M	21.77%11.85M	16.16%43.61M	10.50%11.04M	34.19%10.7M	39.46%12.14M	-10.50%9.73M	-20.94%37.55M	-2.87%9.99M	-26.37%7.97M
Selling and administrative expenses	-12.65%4.27M	-10.59%4.1M	-10.19%18.62M	-6.86%4.66M	-0.58%4.48M	-12.95%4.89M	-18.13%4.59M	-21.45%20.74M	-19.55%5M	-33.09%4.51M
-General and administrative expense	-12.65%4.27M	-10.59%4.1M	-10.19%18.62M	-6.86%4.66M	-0.58%4.48M	-12.95%4.89M	-18.13%4.59M	-21.45%20.74M	-19.55%5M	-33.09%4.51M
Research and development costs	-11.87%6.39M	50.65%7.75M	48.67%24.99M	27.90%6.38M	79.40%6.22M	134.99%7.25M	-2.39%5.14M	-20.30%16.81M	22.64%4.99M	-15.32%3.47M
Operating profit	12.18%-10.66M	-21.77%-11.85M	-16.16%-43.61M	-10.50%-11.04M	-34.19%-10.7M	-39.46%-12.14M	10.50%-9.73M	20.94%-37.55M	2.87%-9.99M	26.37%-7.97M
Net non-operating interest income expense	35.04%1.14M	8.73%747K	191.03%3.18M	55.05%814K	196.11%838K	407.23%842K	477.31%687K	361.18%1.09M	789.83%525K	433.96%283K
Non-operating interest income	35.04%1.14M	8.73%747K	42.65%3.18M	28.80%814K	50.45%838K	64.45%842K	29.87%687K	12.97%2.23M	22.48%632K	1.83%557K
Non-operating interest expense	----	----	----	----	----	----	----	-34.54%1.14M	-76.59%107K	-44.53%274K
Other net income (expense)	175.00%11K	9K	100.04%12K	6K	2K	4K		-29.5M
Gain on sale of security	175.00%11K	--9K	-29.41%12K	--6K	--2K	--4K	----	--17K	----	----
Special income (charges)	----	----	--0	----	----	----	----	---29.52M	----	----
-Less:Impairment of capital assets	----	----	--0	----	----	----	----	--29.52M	----	----
Income before tax	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M
Income tax
Net income	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M
Net income continuous Operations	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M
Minority interest income
Net income attributable to the parent company	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	15.77%-9.51M	-22.66%-11.1M	38.71%-40.42M	73.77%-10.22M	-28.20%-9.86M	-32.26%-11.29M	15.90%-9.05M	-39.58%-65.95M	-280.98%-38.97M	28.64%-7.69M
Basic earnings per share	55.00%-0.45	-21.25%-0.97	39.08%-3.57	73.99%-0.9	-27.94%-0.87	-31.58%-1	16.67%-0.8	-39.19%-5.86	-280.22%-3.46	29.17%-0.68
Diluted earnings per share	55.00%-0.45	-21.25%-0.97	39.08%-3.57	73.99%-0.9	-27.94%-0.87	-31.58%-1	16.67%-0.8	-39.19%-5.86	-280.22%-3.46	29.17%-0.68
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data